Short Communication Open Access
Volume 2 | Issue 3 | DOI: https://doi.org/10.33696/haematology.2.034

Atezolizumab Monotherapy as First-line Treatment in Patients with Advanced BRAFV600 Wild-type Melanoma

  • 1Unidade de Pesquisa Clínica em Oncologia, Porto Alegre, Brazil
  • 2Oncology Department, Oncoclinicas Group, Porto Alegre, Brazil
  • 3Department of Oncology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
+ Affiliations - Affiliations

Corresponding Author

Juliano C. Coelho, juliano.oncologia@gmail.com

Received Date: May 20, 2021

Accepted Date: June 28, 2021

Author Information X